	US 12,478,599 B2
	Nutraceutical composition comprising C60 and ketone esters
Max C. Champie, Buena Vista, CO (US)
Assigned to Max Champie, Buena Vista, CO (US)
Filed by Max C. Champie, Buena Vista, CO (US)
Filed on Aug. 3, 2022, as Appl. No. 17/880,495.
Application 17/880,495 is a division of application No. 16/565,104, filed on Sep. 9, 2019, abandoned.
Application 16/565,104 is a continuation in part of application No. 16/220,890, filed on Dec. 14, 2018, granted, now 11,179,350, issued on Nov. 23, 2021.
Prior Publication US 2022/0370387 A1, Nov. 24, 2022
Int. Cl. A61K 31/122 (2006.01); A61K 31/194 (2006.01); A61K 36/28 (2006.01); A61K 36/71 (2006.01); A61K 47/44 (2017.01)

CPC A61K 31/194 (2013.01) [A61K 31/122 (2013.01); A61K 36/28 (2013.01); A61K 36/71 (2013.01); A61K 47/44 (2013.01)]

8 Claims

1. A nutraceutical composition, comprising a fullerene molecule substituted with a beta-hydroxybutyrate group and further covalently coupled to caprylic acid or capric acid, lecithin, and blackseed oil, wherein the fullerene molecule is C60 and free energy molecules that are not bound to the fullerene, wherein the free energy molecules comprise unbound beta-hydroxybutyrate and an unbound carboxylic acid, wherein the nutraceutical composition is formulated for oral consumption.